Chronic viral hepatitis B with delta-agent
ICD-10 B18.1 is a billable code used to indicate a diagnosis of chronic viral hepatitis b with delta-agent.
Chronic viral hepatitis B with delta-agent is a liver infection caused by the hepatitis B virus (HBV) in conjunction with the hepatitis D virus (HDV). This condition is characterized by the presence of both viruses, leading to a more severe form of hepatitis. The delta agent, or HDV, can only infect individuals who are already infected with HBV, making the co-infection particularly concerning. Chronic hepatitis B can lead to significant liver damage, including cirrhosis and hepatocellular carcinoma. Patients may remain asymptomatic for years, but chronic infection can result in fatigue, jaundice, and abdominal pain. Management of chronic hepatitis B with delta-agent involves regular monitoring of liver function, antiviral therapy, and lifestyle modifications to reduce liver strain. The presence of the delta agent complicates the disease course and treatment, often requiring more aggressive management strategies. Understanding the transmission routes, which include blood-to-blood contact and sexual transmission, is crucial for prevention and control measures.
Detailed history of liver disease, lab results for HBV and HDV, and treatment plans.
Management of chronic hepatitis B with delta-agent, monitoring for liver complications.
Ensure all lab results are documented to support the diagnosis and treatment plan.
History of exposure, vaccination status, and treatment response.
Assessment of patients with acute and chronic hepatitis B and delta co-infection.
Documenting the patient's risk factors for transmission and co-infections.
Used to confirm the diagnosis of hepatitis B.
Document the reason for testing and results.
Hepatology specialists should ensure comprehensive testing for both HBV and HDV.
The delta agent (HDV) complicates hepatitis B infection, leading to more severe liver disease and a higher risk of complications such as cirrhosis and liver cancer.
